EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. A

Comparison of liquid chromatography and supercritical fluid chromatography coupled to compact single quadrupole mass spectrometer for targeted in vitro metabolism assay.


PMID 25456603

Abstract

The goal of this study was to evaluate the combination of powerful chromatographic methods and compact single quadrupole MS device for simple in vitro cytochrome P450 (CYP) inhibition assay, instead of more expensive triple quadrupole MS/MS detectors. For this purpose, two modern chromatographic approaches (ultra-high pressure liquid chromatography (UHPLC) and ultra-high performance supercritical fluid chromatography (UHPSFC)) were tested in combination with simple MS detector. To show the applicability for an in vitro CYP-mediated metabolism assay using the cocktail approach, a method was first developed in UHPLC-MS to separate a mixture of 8 probe substrates and 8 CYP-specific metabolites. A screening procedure was initially applied to determine the best combination of a column, an organic modifier and a mobile-phase pH, followed by fine tuning of the conditions (i.e., gradient profile, temperature and pH) using HPLC modelling software. A similar sequential method development procedure was also evaluated for UHPSFC-MS. For method development, where peak tracking is necessary, the use of single quadrupole MS was found to be extremely valuable for following the investigated analytes. Ultimately, a baseline separation of the 16 compounds was achieved in both UHPLC-MS and UHPSFC-MS with an analysis time of less than 7 min. In a second series of experiments, sensitivity was evaluated, and LOQ values were between 2 and 100 ng/mL in UHPLC-MS, while they ranged from 2 to 200 ng/mL in UHPSFC-MS. Based on the concentrations employed for the current in vitro phase I metabolism assay, these LOQ values were appropriate for this type of application. Finally, the two analytical methods were applied to in vitro CYP-dependent metabolism testing. Two well-known phytochemical inhibitors, yohimbine and resveratrol, were investigated, and reliable conclusions were drawn from these experiments with both UHPLC-MS and UHPSFC-MS. At the end, the proposed strategy of optimized chromatography combined with simple MS device has been shown to potentially compete with the widely used combination of generic chromatography and highly selective MS/MS device for simple in vitro CYP inhibition assays. In addition, our analytical method may be easier to use in a routine environment; the instrument cost is significantly reduced and the two developed methods fit for purpose.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

1570428
2-Propanol, United States Pharmacopeia (USP) Reference Standard
C3H8O
PHR1072
2-Propanol, Pharmaceutical Secondary Standard; Certified Reference Material
C3H8O
91237
2-Propanol, analytical standard
C3H8O
A7302
4-Acetamidophenol, 98%
C8H9NO2
UC148
6-Hydroxychlorzoxazone, ≥98% (HPLC)
C7H4ClNO3
C188
6-Hydroxychlorzoxazone, solid
C7H4ClNO3
A7085
Acetaminophen, BioXtra, ≥99.0%
C8H9NO2
A3035
Acetaminophen, analytical standard
C8H9NO2
A5000
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
C8H9NO2
1003009
Acetaminophen, United States Pharmacopeia (USP) Reference Standard
C8H9NO2
PHR1005
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
C8H9NO2
A-064
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
C8H9NO2
09859
Ammonium hydroxide solution, BioUltra, ~1 M NH3 in H2O (T)
H5NO
40205
Ammonium hydroxide solution, ≥25% NH3 in H2O, semiconductor grade PURANAL (Honeywell 17814)
H5NO
01-4362
Ammonium hydroxide solution, 28% NH3 in H2O, suitable for determination of toxic metals
H5NO
B102
Bupropion hydrochloride, ≥98% (HPLC), solid
C13H18ClNO · HCl
1078733
Bupropion hydrochloride, United States Pharmacopeia (USP) Reference Standard
C13H18ClNO · HCl
C4397
Chlorzoxazone
C7H4ClNO2
72609
Coumarin, certified reference material, TraceCERT®
C9H6O2
C4261
Coumarin, ≥99% (HPLC)
C9H6O2
W526509
Coumarin, ≥98%
C9H6O2
01260595
Coumarin, primary reference standard
C9H6O2
Y0000438
Coumarin, European Pharmacopoeia (EP) Reference Standard
C9H6O2
1180503 Dextromethorphan, United States Pharmacopeia (USP) Reference Standard
C18H25NO
UC205
Dextrorphan
C17H23NO
F8514
Flurbiprofen, cyclooxygenase inhibitor
C15H13FO2
F0285200
Flurbiprofen, European Pharmacopoeia (EP) Reference Standard
C15H13FO2
PHR1499
Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material
C15H13FO2
246654
Heptane, anhydrous, 99%
C7H16
650536
Heptane, HPLC Plus, for HPLC, GC, and residue analysis, 99%
C7H16